Dr. Nuno Abecasis
Director of General Surgery at IPO Lisboa · Surgical Oncologist · Peritoneal Carcinomatosis Specialist
Portuguese Oncology Institute of Lisbon Francisco Gentil (IPO Lisboa)
Career Trajectory & Contribution
Dr. Nuno Abecasis (often searched and cited as Dr. Nuno Abecassis) is one of Portugal’s most distinguished surgical oncologists, currently serving as Director of the General Surgery Service at the Portuguese Oncology Institute of Lisbon Francisco Gentil (IPO Lisboa), the nation’s foremost cancer center.
With over three decades dedicated to complex tumor surgery, he pioneered advanced multimodal interventions including cytoreductive surgery combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC), surgical treatment of advanced thyroid carcinomas, soft tissue sarcomas, and gastrointestinal malignancies.
A key leader in medical governance and former Vice-President of the Portuguese Society of Surgery (SPCir), Dr. Nuno Abecasis bridges laboratory oncology at i3S directly to the operating theater, ensuring BolsaLAB grants evaluate real clinical translatability and bedside impact.
Specialty Areas & Research Domains
Evaluating clinical translational potential, medical feasibility, and direct relevance to cancer patient survival and surgical care.
Strict recusal rule for applications involving direct clinical trials or hospital departments under his supervision.
